The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
110433173 11043317 3 F 20150111 20160727 20150417 20160804 EXP US-ASTRAZENECA-2015SE07151 ASTRAZENECA 27325.00 DY F Y 76.20000 KG 20160804 CN US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
110433173 11043317 1 PS BYETTA EXENATIDE 1 Subcutaneous 21773 SOLUTION FOR INJECTION IN PRE-FILLED PEN
110433173 11043317 2 SS BYETTA EXENATIDE 1 Subcutaneous 10 UG, UNKNOWN PEN 21773 SOLUTION FOR INJECTION IN PRE-FILLED PEN
110433173 11043317 3 SS BYETTA EXENATIDE 1 Subcutaneous 21773 10 UG SOLUTION FOR INJECTION IN PRE-FILLED PEN BID
110433173 11043317 4 SS BYETTA EXENATIDE 1 Subcutaneous 2.4 ML Q12H 21773 SOLUTION FOR INJECTION IN PRE-FILLED PEN
110433173 11043317 5 SS BYDUREON EXENATIDE 1 Subcutaneous Y U 0 2 MG /wk
110433173 11043317 6 C SYNTHROID LEVOTHYROXINE SODIUM 1 Oral 0
110433173 11043317 7 C BENAZEPRIL BENAZEPRIL HYDROCHLORIDE 1 Oral 0
110433173 11043317 8 C DIGITEK DIGOXIN 1 Oral 10.0MG UNKNOWN 0 10 MG
110433173 11043317 9 C METFORMIN METFORMIN HYDROCHLORIDE 1 Oral 0 500 MG QID
110433173 11043317 10 C METFORMIN METFORMIN HYDROCHLORIDE 1 Oral 0 500 MG BID
110433173 11043317 11 C GLIPIZIDE. GLIPIZIDE 1 Oral 0 10 MG BID
110433173 11043317 12 C GLIPIZIDE. GLIPIZIDE 1 Oral BID 0
110433173 11043317 13 C LEVOTHYROXINE. LEVOTHYROXINE 1 0 125 MG QD

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
110433173 11043317 1 Type 2 diabetes mellitus
110433173 11043317 2 Type 2 diabetes mellitus
110433173 11043317 3 Type 2 diabetes mellitus
110433173 11043317 4 Type 2 diabetes mellitus
110433173 11043317 5 Type 2 diabetes mellitus
110433173 11043317 6 Thyroid disorder
110433173 11043317 7 Blood pressure abnormal
110433173 11043317 9 Diabetes mellitus
110433173 11043317 10 Diabetes mellitus
110433173 11043317 11 Diabetes mellitus
110433173 11043317 12 Diabetes mellitus
110433173 11043317 13 Thyroid disorder

Outcome of event

Event ID CASEID OUTC COD
110433173 11043317 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
110433173 11043317 Blood glucose increased
110433173 11043317 Decreased appetite
110433173 11043317 Diarrhoea
110433173 11043317 Drug dose omission
110433173 11043317 Drug hypersensitivity
110433173 11043317 Fall
110433173 11043317 Fatigue
110433173 11043317 Feeling abnormal
110433173 11043317 Gallbladder perforation
110433173 11043317 Heart rate increased
110433173 11043317 Hiccups
110433173 11043317 Intentional product misuse
110433173 11043317 Malaise
110433173 11043317 Nausea
110433173 11043317 Product quality issue
110433173 11043317 Upper limb fracture
110433173 11043317 Vomiting
110433173 11043317 Weight fluctuation

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
110433173 11043317 4 20160725 0
110433173 11043317 5 20150111 20150111 0